Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1977 Jan;74(1):253–257. doi: 10.1073/pnas.74.1.253

Chromosome mapping of the genes that control differentiation and malignancy in myeloid leukemic cells.

J I Azumi, L Sachs
PMCID: PMC393237  PMID: 264678

Abstract

The chromosome banding pattern has been analyzed in clones of mouse myeloid leukemic cells that differ in their ability to be induced to differentiate by the protein inducer MGI (macrophage and granulocyte inducer). None of the clones had a completely normal diploid banding pattern. The clones studied were either MGI+ (that can be induced to form Fc and C3 rosettes), a stage in the differentiation of myeloid cells, or MGI- (that cannot be induced to form these rosettes). All six cultured clones of MGI- cells from myeloid leukemias independently produced in six separate animals showed a loss of a piece of one chromosome 2 and this abnormal chromosome was maintained in leukemias derived from the cultured cells. This loss was not found in MGI+ clones or lymphoid leukemias. Five MGI+ mutants, derived from an MGI- clone with a loss of a piece of one chromosome 2, one normal chromosome 12, and two translocated chromosomes 12, maintained the abnormal chromosome 2 but lost either the one normal or one of these translocated chromosome 12. These results indicate that chromosomes 2 and 12 carry genes that control the differentiation of myeloid leukemic cells and that inducibility by MGI is controlled by the balance between these genes. We suggest that these chromosomes also carry genes that control the malignancy of these cells.

Full text

PDF
253

Images in this article

255Image
on p.255

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Benedict W. F., Rucker N., Mark C., Kouri R. E. Correlation between balance of specific chromosomes and expression of malignancy in hamster cells. J Natl Cancer Inst. 1975 Jan;54(1):157–162. doi: 10.1093/jnci/54.1.157. [DOI] [PubMed] [Google Scholar]
  2. Bianco C., Patrick R., Nussenzweig V. A population of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes. I. Separation and characterization. J Exp Med. 1970 Oct 1;132(4):702–720. doi: 10.1084/jem.132.4.702. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bloch-Shtacher N., Sachs L. Chromosome balance and the control of malignancy. J Cell Physiol. 1976 Jan;87(1):89–100. doi: 10.1002/jcp.1040870112. [DOI] [PubMed] [Google Scholar]
  4. Bradley T. R., Metcalf D. The growth of mouse bone marrow cells in vitro. Aust J Exp Biol Med Sci. 1966 Jun;44(3):287–299. doi: 10.1038/icb.1966.28. [DOI] [PubMed] [Google Scholar]
  5. Clements G. B., Fenyö E. M., Klein G. In vitro derived mouse A9 cell clones differing in malignancy: analysis by somatic cell hybridization with YACIR lymphoma cell clones. Proc Natl Acad Sci U S A. 1976 Jun;73(6):2004–2007. doi: 10.1073/pnas.73.6.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Codish S. D., Paul B. Reversible appearance of a specific chromosome which suppresses malignancy. Nature. 1974 Dec 13;252(5484):610–612. doi: 10.1038/252610a0. [DOI] [PubMed] [Google Scholar]
  7. Croce C. M., Aden D., Koprowski H. Somatic cell hybrids between mouse peritoneal macrophages and simian-virus-40-transformed human cells: II. Presence of human chromosome 7 carrying simin virus 40 genome in cells of tumors induced by hybrid cells. Proc Natl Acad Sci U S A. 1975 Apr;72(4):1397–1400. doi: 10.1073/pnas.72.4.1397. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Dofuku R., Biedler J. L., Spengler B. A., Old L. J. Trisomy of chromosome 15 in spontaneous leukemia of AKR mice. Proc Natl Acad Sci U S A. 1975 Apr;72(4):1515–1517. doi: 10.1073/pnas.72.4.1515. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Fibach E., Gerassi E., Sachs L. Induction of colony formation in vitro by human lymphocytes. Nature. 1976 Jan 15;259(5539):127–129. doi: 10.1038/259127a0. [DOI] [PubMed] [Google Scholar]
  10. Fibach E., Hayashi M., Sachs L. Control of normal differentiation of myeloid leukemic cells to macrophages and granulocytes. Proc Natl Acad Sci U S A. 1973 Feb;70(2):343–346. doi: 10.1073/pnas.70.2.343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Fibach E., Sachs L. Control of normal differentiation of myeloid leukemic cells. VIII. Induction of differentiation to mature granulocytes in mass culture. J Cell Physiol. 1975 Oct;86(2 Pt 1):221–230. doi: 10.1002/jcp.1040860205. [DOI] [PubMed] [Google Scholar]
  12. Harris H., Miller O. J., Klein G., Worst P., Tachibana T. Suppression of malignancy by cell fusion. Nature. 1969 Jul 26;223(5204):363–368. doi: 10.1038/223363a0. [DOI] [PubMed] [Google Scholar]
  13. Hayashi M., Fibach E., Sachs L. Control of normal differentiation of myeloid leukemic cells. V. Normal differentiation in aneuploid leukemic cells and the chromosome banding pattern of D+ and D minus clones. Int J Cancer. 1974 Jul 15;14(1):40–48. doi: 10.1002/ijc.2910140106. [DOI] [PubMed] [Google Scholar]
  14. Hitotsumachi S., Rabinowitz Z., Sachs L. Ciromosomal control of reversion in transformed cells. Nature. 1971 Jun 25;231(5304):511–514. doi: 10.1038/231511a0. [DOI] [PubMed] [Google Scholar]
  15. Ichikawa Y. Differentiation of a cell line of myeloid leukemia. J Cell Physiol. 1969 Dec;74(3):223–234. doi: 10.1002/jcp.1040740303. [DOI] [PubMed] [Google Scholar]
  16. Ichikawa Y., Pluznik D. H., Sachs L. In vitro control of the development of macrophage and granulocyte colonies. Proc Natl Acad Sci U S A. 1966 Aug;56(2):488–495. doi: 10.1073/pnas.56.2.488. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Klein G., Bregula U., Wiener F., Harris H. The analysis of malignancy by cell fusion. I. Hybrids between tumour cells and L cell derivatives. J Cell Sci. 1971 May;8(3):659–672. doi: 10.1242/jcs.8.3.659. [DOI] [PubMed] [Google Scholar]
  18. Levan O., Levan A. Specific chromosome changes in malignancy: studies in rat sarcomas induced by two polycyclic hydrocarbons. Hereditas. 1975;79(2):161–198. doi: 10.1111/j.1601-5223.1975.tb01475.x. [DOI] [PubMed] [Google Scholar]
  19. Lotem J., Sachs L. Control of Fc and C3 receptors on myeloid leukemic cells. J Immunol. 1976 Aug;117(2):580–586. [PubMed] [Google Scholar]
  20. Lotem J., Sachs L. Different blocks in the differentiation of myeloid leukemic cells. Proc Natl Acad Sci U S A. 1974 Sep;71(9):3507–3511. doi: 10.1073/pnas.71.9.3507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Manolov G., Manolova Y. Marker band in one chromosome 14 from Burkitt lymphomas. Nature. 1972 May 5;237(5349):33–34. doi: 10.1038/237033a0. [DOI] [PubMed] [Google Scholar]
  22. NOWELL P. C., HUNGERFORD D. A. Chromosome studies on normal and leukemic human leukocytes. J Natl Cancer Inst. 1960 Jul;25:85–109. [PubMed] [Google Scholar]
  23. Paran M., Sachs L., Barak Y., Resnitzky P. In vitro induction of granulocyte differentiation in hematopoietic cells from leukemic and non-leukemic patients. Proc Natl Acad Sci U S A. 1970 Nov;67(3):1542–1549. doi: 10.1073/pnas.67.3.1542. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Pluznik D. H., Sachs L. The cloning of normal "mast" cells in tissue culture. J Cell Physiol. 1965 Dec;66(3):319–324. doi: 10.1002/jcp.1030660309. [DOI] [PubMed] [Google Scholar]
  25. Pluznik D. H., Sachs L. The induction of clones of normal mast cells by a substance from conditioned medium. Exp Cell Res. 1966 Oct;43(3):553–563. doi: 10.1016/0014-4827(66)90026-7. [DOI] [PubMed] [Google Scholar]
  26. Rabinowitz Z., Sachs L. Control of the reversion of properties in transformed cells. Nature. 1970 Jan 10;225(5228):136–139. doi: 10.1038/225136a0. [DOI] [PubMed] [Google Scholar]
  27. Rowley J. D. Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature. 1973 Jun 1;243(5405):290–293. doi: 10.1038/243290a0. [DOI] [PubMed] [Google Scholar]
  28. Rowley J. D. Nonrandom chromosomal abnormalities in hematologic disorders of man. Proc Natl Acad Sci U S A. 1975 Jan;72(1):152–156. doi: 10.1073/pnas.72.1.152. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Sachs L. Regulation of membrane changes, differentiation, and malignancy in carcinogenesis. Harvey Lect. 1974;68:1–35. [PubMed] [Google Scholar]
  30. Standard karyotype of the mouse, Mus musculus. J Hered. 1972 Mar-Apr;63(2):69–72. [PubMed] [Google Scholar]
  31. Vlodavsky I., Fibach E., Sachs L. Control of normal differentiation of myeloid leukemic cells. X. Glucose utilization, cellular ATP and associated membrane changes in D+ and D- cells. J Cell Physiol. 1975 Dec;87(2):167–177. doi: 10.1002/jcp.1040870205. [DOI] [PubMed] [Google Scholar]
  32. Wiener F., Klein G., Harris H. The analysis of malignancy by cell fusion. V. Further evidence of the ability of normal diploid cells to suppress malignancy. J Cell Sci. 1974 Jun;15(1):177–183. doi: 10.1242/jcs.15.1.177. [DOI] [PubMed] [Google Scholar]
  33. Yamamoto T., Rabinowitz Z., Sachs L. Identification of the chromosomes that control malignancy. Nat New Biol. 1973 Jun 20;243(129):247–250. doi: 10.1038/newbio243247a0. [DOI] [PubMed] [Google Scholar]
  34. Zech L., Haglund U., Nilsson K., Klein G. Characteristic chromosomal abnormalities in biopsies and lymphoid-cell lines from patients with Burkitt and non-Burkitt lymphomas. Int J Cancer. 1976 Jan 15;17(1):47–56. doi: 10.1002/ijc.2910170108. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES